Sponsor Pipeline

ABL Bio, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07158918 ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or… Solid Tumors Recruiting
Phase 1
NCT04762641 This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the… Advanced Solid Tumor Recruiting
NCT06126666 A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors Advanced Solid Tumor Recruiting
Get alerts when ABL Bio, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free